Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 107, Issue 11, 2013, Pages 1781-1788

  Bodlet, Aline ^a   Maury, Gisèle ^a   Jamart, Jacques ^a   Dahlqvist, Caroline ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

du Bois score; Emphysema; Idiopathic pulmonary fibrosis; Lung function tests

Indexed keywords

ACETYLCYSTEINE; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DU BOIS SCORE; EMPHYSEMA; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OXYGEN THERAPY; PLETHYSMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SMOKING; SPIROMETRY; THORAX;

DU BOIS SCORE; EMPHYSEMA; IDIOPATHIC PULMONARY FIBROSIS; LUNG FUNCTION TESTS;

ACETYLCYSTEINE; AGED; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PULMONARY DIFFUSING CAPACITY; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 84887056143     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.039     Document Type: Article

References (25)

1. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, K.K. Brown, T.V. Colby, J.F. Cordier, K.R. Flaherty, and J.A. Lasky An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 6 2011 Mar 15 788 824
2. Moisés Selman, Talmadge E. King Jr., and Annie Pardo Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy Ann Intern Med 134 2001 136 151
3. C.K. Oh, L.A. Murray, and N.A. Molfino Smoking and idiopathic pulmonary fibrosis Pulm Med 2012 2012 808260
4. J. Vestbo, and R. Rodriguez-Roisin Global strategy for diagnosis, management, and prevention of COPD (revised 2011) Global Initiative for Chronic Obstructive Lung Disease 2011 p. 4 [chapter 1]
5. V. Cottin, H. Nunes, P.-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J.-F. Cordier and the Groupe d'Etude et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P) Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur Respir J 26 2005 586 593
6. V. Cottin, and J.F. Cordier The syndrome of combined pulmonary fibrosis and emphysema Chest 136 2009 1 2
7. M.D. Jankowich, M. Polsky, M. Klein, and S. Rounds Heterogeneity in combined pulmonary fibrosis and emphysema Respiration 75 2008 411 417
8. C. Ryerson, T. Hartman, B. Elicker, B. Ley, J. Lee, M. Abbritti, K. Jones, T. King, J. Ryu, and H. Collard Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Chest 144 1 2013 234 240
9. T. Akagi, T. Matsumoto, T. Harada, M. Tanaka, T. Kuraki, M. Fujita, and K. Watanabe Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis Respir Med 103 2009 1209 1215
10. G. Thabut, H. Mal, Y. Castier, O. Groussard, O. Brugiere, R. Marrash-Chahla, G. Leseche, and M. Fournier Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis J Thorac Cardiovasc Surg 126 2003 469 475
11. J.S. Lee, J.H. Ryu, B.M. Elicker, C.P. Lydell, K.D. Jones, P.J. Wolters, T.E. King Jr., and H.R. Collard Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 12 2011 Dec 15 1390 1394
12. V. Cottin, J. Le Pavec, G. Prévot, H. Mal, M. Humbert, G. Simonneau, J.-F. Cordier, and P. GERMO Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Eur Respir J 35 2010 105 111
13. D.J. Lederer, S.M. Arcasoy, J.S. Wilt, F. D'Ovidio, J.R. Sonett, and S.M. Kawut Six-minute walk distance predicts waiting list survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 6 2006 Sep 15 659 664
14. S.L. Schmidt, A.M. Nambiar, and N. Tayob Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Eur Respir J 38 2011 176 183
15. F. Soares Pires, P. Caetano Mota, N. Melo, D. Costa, J.M. Jesus, R. Cunha, S. Guimarães, C. Souto-Moura, and A. Morais Idiopathic pulmonary fibrosis - clinical presentation, outcome and baseline prognostic factors in a Portuguese cohort Rev Port Pneumol 19 1 2013 19 27
16. K. Miki, R. Maekura, T. Hiraga, Y. Okuda, T. Okamoto, and A. Hirotani Impairments and prognostic factors for survival in patients with pulmonary idiopathic pulmonary fibrosis Respir Med 97 2003 482 490
17. R.M. du Bois, D. Weycker, C. Albera, W.Z. Bradford, U. Costabel, A. Kartashov, L. Lancaster, P.W. Noble, G. Raghu, S.A. Sahn, J. Szwarcberg, M. Thomeer, D. Valeyre, and T.E. King Jr. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 4 2011 Aug 15 459 466
18. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P.M. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi, and J. Wanger Standardisation of spirometry Eur Respir J 26 2005 319 338
19. P.R. Slev, B.G. Williams, T.O. Harville, E.R. Ashwood, and J.A. Bornhorst Efficacy of the detection of the alpha1-antitrypsin "Z" deficiency variant by routine serum protein electrophoresis Am J Clin Pathol 130 4 2008 Oct 568 572
20. M. Mejía, G. Carrillo, J. Rojas-Serrano, A. Estrada, T. Suárez, D. Alonso, E. Barrientos, M. Gaxiola, C. Navarro, and M. Selman Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension Chest 136 1 2009 Jul 10 15
21. R.M. du Bois, D. Weycker, C. Albera, W.Z. Bradford, U. Costabel, A. Kartashov, T.E. King Jr., L. Lancaster, P.W. Noble, S.A. Sahn, M. Thomeer, D. Valeyre, and A.U. Wells Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference Am J Respir Crit Care Med 184 12 2011 Dec 15 1382 1389
22. H.R. Collard, T.E. King Jr., B.B. Bartelson, J.S. Vourlekis, M.I. Schwarz, and K.K. Brown Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 5 2003 Sep 1 538 542
23. H. Nadrous, P. Pellika, M. Krowka, K. Swanson, N. Chaowalit, P. Decker, and J. Ryu Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Chest 128 2005 2393 2399
24. M.D. Jankowich, and S. Rounds Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema Lung 188 5 2010 365 373
25. K. Kurashima, N. Takayanagi, N. Tsuchiya, T. Kanauchi, M. Ueda, T. Hoshi, Y. Miyahara, and Y. Sugita The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis Respirology 15 2010 843 848